SGMT

Sagimet Biosciences Inc.

Price

$9.17

return (12m)

25.72%

p/e

-10.34

p/bv

1.90

DIVIDEND YIELD

0.00%

SGMT price

Sagimet Biosciences Inc.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SGMT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-14.63%

3 months

17.65%

1 year

25.72%

2 years

122.45%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SGMT

Valuation

P/E

-10.34

Sector 7.50

Industry 7.50

P/BV

1.90

Sector 1.77

Industry 1.77

P/Revenue (PSR)

Sector 1.72

Industry 1.72

EV/EBITDA

-15.59

Sector -842.79

Industry -842.79

EV/EBIT

-15.59

Sector -1,519.48

Industry -1,519.48

P/EBITDA

-9.25

Sector -14.40

Industry -14.40

P/EBIT

-9.25

Sector -12.63

Industry -12.63

P/Total Assets

1.85

Sector 0.83

Industry 0.83

P/Net Current Assets

2.06

Sector -1.96

Industry -1.96

P/Working Capital

2.04

Sector -4,656.37

Industry -4,656.37

EPS

-0.89

Sector 0.70

Industry 0.70

BVPS

4.82

Sector 9.63

Industry 9.63

Efficiency

Gross Margin

0.00%

Sector 35.53%

Industry 35.53%

EBITDA Margin

Sector -7,056,892.18%

Industry -7,056,892.18%

EBIT Margin

Sector -159.46%

Industry -159.46%

Operating Margin

0.00%

Sector 4.35%

Industry 4.35%

Net Profit Margins

0.00%

Sector 2.37%

Industry 2.37%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-18.38%

Sector 2.14%

Industry 2.14%

ROA

-17.87%

Sector -0.82%

Industry -0.82%

ROIC

-644.15%

Sector -120.08%

Industry -120.08%

Dividends

Dividend yield

0.00%

Sector 0.53%

Industry 0.53%

Payout

Sector 10.02%

Industry 10.02%

Debt

Current Ratio

45.02

Sector 1.47

Industry 1.47

Net Debt / EBITDA

15.18

Sector -20.49

Industry -20.49

Net Debt / EBIT

15.18

Sector -168,192,801.50

Industry -168,192,801.50

Net Debt / Equity

-0.94

Sector -0.78

Industry -0.78

Gross Debt / Equity

0.00

Sector -0.51

Industry -0.51

Equity/Assets

0.97

Sector 0.43

Industry 0.43

Liabilities/Assets

0.03

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals SGMT

DRAG THE FRAME TO SEE MORE DATA

SGMT - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Sagimet Biosciences Inc.

Sagimet Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2023

Time since IPO - 3 years

16

Employees

Sagimet Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $486.79 million, with shareholders equity totaling $256.16 million.

The company employs approximately 16 people and operates in the Others sector, within the Others industry.

Over the past 12 months, Sagimet Biosciences Inc. reported $- in revenue, generating net income of $-47.08 million.

Key financial metrics include a P/E ratio of -10.34, a price-to-book (P/B) ratio of 1.90, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SGMT.

Market cap

$486.79 million

Net worth

$256.16 million

$256,155,000.00

Assets

$263.43 million

$263,430,000.00

Total Shares Outstanding

53.11 million

53,114,000

Average Daily Trading Volume

$1.30 million

$1,302,618.78

Sector

Others

Industry

Others

SGMT

SGMT revenue and profits

Financial Results SGMT

DRAG THE FRAME TO SEE MORE DATA

SGMT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$368.07 4,90% (12M)

P/E

23.51

2.46%

ROE

13.51%

P/BV

3.18

SHEL - Shell PLC ADR

$95.74 35,65% (12M)

P/E

10.30

3.16%

ROE

14.29%

P/BV

1.47

STLA - Stellantis NV

$4.37 --59,26% (12M)

P/E

-0.50

0.00%

ROE

-35.93%

P/BV

0.18

COR - Cencora Inc.

$307.21 2,24% (12M)

P/E

22.61

0.78%

ROE

81.03%

P/BV

18.32

ALIZY - Allianz SE ADR

$46.75 --19,31% (12M)

P/E

12.88

2.91%

ROE

17.89%

P/BV

2.30

TTE - TotalEnergies SE ADR

$84.50 48,84% (12M)

P/E

6.86

4.78%

ROE

21.42%

P/BV

1.47

NSRGY - Nestle SA ADR

$90.02 0,79% (12M)

P/E

10.81

4.45%

ROE

58.05%

P/BV

6.27

ELV - Elevance Health Inc

$386.86 12,56% (12M)

P/E

19.87

1.71%

ROE

9.84%

P/BV

1.96